April 3, 2020 Johns Hopkins in Baltimore was given FDA approval to test a blood plasma therapy to treat COVID-19 patients.  The trial will use blood serum (a straw colored liquid left after the clotting of plasma), collected from recovered COVID-19 patients. This trial will evaluate convalescent serum as a preventive treatment for infection in … Continue reading Convalescent serum for COVID-19